| Balance sheet (USD) | Q2 2026 ended Jun 28, 2026 | Q1 2026 ended Mar 29, 2026 | Q4 2025 ended Dec 31, 2025 | Q3 2025 ended Sep 28, 2025 | Q2 2025 ended Jun 29, 2025 | Q1 2025 ended Mar 30, 2025 | Q4 2024 ended Dec 31, 2024 | Q3 2024 ended Sep 29, 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 976.00M | 1.70B | 1.14B | 1.34B | 1.64B | 1.43B | 1.04B | 1.09B |
| Short-term investments | 7.28B | 8.19B | 9.18B | 10.12B | 9.53B | 13.95B | 10.88B | 6.85B |
| Receivables | 12.49B | 12.59B | 11.87B | 14.26B | 12.08B | 11.85B | 11.46B | 14.45B |
| Inventory | 9.95B | 10.67B | 10.65B | 11.47B | 11.67B | 10.85B | 10.85B | 11.72B |
| Total current assets | 41.36B | 42.82B | 42.90B | 46.92B | 43.70B | 45.86B | 50.36B | 43.22B |
| Property, plant and equipment | 19.03B | 19.40B | 19.32B | 18.88B | 18.78B | 18.35B | 18.39B | 18.54B |
| Goodwill and intangibles | 118.47B | 123.97B | 125.00B | 120.42B | 121.70B | 122.42B | 123.94B | 128.56B |
| Total assets | 201.13B | 207.62B | 208.16B | 208.73B | 206.09B | 208.03B | 213.40B | 219.48B |
| Accounts payable | 4.58B | 4.51B | 5.24B | 5.02B | 5.17B | 5.24B | 5.63B | 5.31B |
| Total current liabilities | 32.65B | 34.35B | 36.98B | 36.60B | 37.73B | 36.45B | 42.99B | 43.21B |
| Long-term debt | 60.49B | 60.56B | 61.64B | 57.41B | 57.50B | 57.64B | 57.41B | 58.00B |
| Total liabilities | 115.64B | 117.21B | 121.39B | 115.64B | 117.08B | 117.39B | 124.90B | 126.92B |
| Retained earnings | 112.09B | 117.24B | 114.61B | 121.15B | 117.61B | 119.59B | 116.72B | 121.06B |
| Shareholders' equity | 85.19B | 90.10B | 86.48B | 92.80B | 88.69B | 90.34B | 88.20B | 92.29B |
| Total debt | 63.19B | 64.45B | 64.80B | 61.71B | 61.80B | 62.26B | 66.80B | 73.54B |
| Net debt | 62.22B | 62.75B | 63.65B | 60.37B | 60.16B | 60.83B | 65.76B | 72.45B |
From Pfizer's 10-K and 10-Q filings with the SEC. Fourth quarters, and quarters where the company only reported year-to-date totals, are worked out by subtracting the earlier quarters. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read balance sheet or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.